Isomorphic Labs raises $5 billion Series C for AI drug design
Isomorphic Labs, the AI drug discovery company led by Sir Demis Hassabis, has raised $5 billion in a Series C round, the company said in a press release. Greenoaks and Sequoia Capital co-led the round alongside Andreessen Horowitz and several other new investors, with continued significant investment from Alphabet and participation from existing investors.
The company, founded in 2021, is scaling IsoDDE, its proprietary drug design engine that combines foundational simulation models across therapeutic areas and drug types, and the pipeline of drug candidates it has designed with AI. The new money will go into maturing IsoDDE, moving deeper into new biology and building a partner ecosystem to study the mechanisms of disease. "Our drug design engine is generating molecules with unprecedented precision and speed," Hassabis said.
The release does not give a valuation. Bloomberg reported in October that Isomorphic was in talks at a valuation of $40 billion to $50 billion, Tech Funding News and SiliconANGLE reported at the time. Isomorphic raised $2.1 billion in May, and it works with drugmakers through research partnerships, including deals worth nearly $3 billion with Eli Lilly and Novartis signed in 2024.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 17 OpenAI says its computer-use agents can handle clinicians' EHR tasks, with CVS Health and Cigna among users Nov 16 FDA starts calling AI 'Super Intelligence' under Trump executive order Nov 16 Healthcare AI spending grew 2.5x to $3.7B in 2026, Menlo Ventures says Nov 16 Remedy Robotics raises $62M Series B for AI-enabled endovascular robot Nov 16 Lumeris launches Tom Health to extend primary care with AIAI in Europe
Daily AI news from Europe, chosen by Rene van Pelt: European companies, the EU and the UK, chips and data centres, deals and regulation, in a few minutes.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Atlas Bio raises $12.5 million for virtual drug trials
ALLOX Raises $10.5 Million for AI Drug Discovery Platform
Pathos AI Raises $237 Million at $3 Billion Valuation
Potential Sciences Raises Eight Figure Round With Sovereign AI Backing
Ocient raises $100 million for large scale AI data platform
Daily AI Brief: the AI news that matters, in your inbox.